P Kirchhof

Summary

Affiliation: University of Birmingham
Country: UK

Publications

  1. pmc Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue
    Peter C Kahr
    Department of Cardiology and Angiology, University Hospital Munster, Munster, Germany
    PLoS ONE 6:e26389. 2011
  2. pmc Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)
    Paulus Kirchhof
    University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, City Hospital, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, Institute of Biomedical Research IBR 136, Birmingham B15 2TT, UK
    Europace 16:6-14. 2014
  3. doi request reprint Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial
    Paulus Kirchhof
    University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, Birmingham, UK Department of Cardiovascular Medicine, University Hospital Munster, Munster, Germany Kompetenznetz Vorhofflimmern e V AFNET e V, c o University of Münster, Munster, Germany Electronic address
    Am Heart J 166:442-8. 2013
  4. doi request reprint Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference
    Paulus Kirchhof
    Hospital of University of Münster, Munster, Germany
    Thromb Haemost 106:1012-9. 2011
  5. doi request reprint Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial
    Paulus Kirchhof
    Department of Cardiology and Angiology, Hospital of the University of Münster, Germany
    Lancet 380:238-46. 2012
  6. doi request reprint [Atrial fibrillation: current recommendations for diagnosis and treatment]
    P Kirchhof
    Institute for Biomedical Research, University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, B15 2TT Birmingham, United Kingdom
    Internist (Berl) 54:583-95. 2013
  7. doi request reprint Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions
    P Kirchhof
    Department of Cardiology and Angiology, University Hospital Munster, Albert Schweitzer Straße 33, D 48149 Munster, Germany
    Thromb Haemost 105:1010-23. 2011

Detail Information

Publications7

  1. pmc Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue
    Peter C Kahr
    Department of Cardiology and Angiology, University Hospital Munster, Munster, Germany
    PLoS ONE 6:e26389. 2011
    ..We therefore systematically studied the molecular composition of left and right atrial tissue in adult murine and human atria...
  2. pmc Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)
    Paulus Kirchhof
    University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, City Hospital, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, Institute of Biomedical Research IBR 136, Birmingham B15 2TT, UK
    Europace 16:6-14. 2014
    ..We sought to describe the management of patients with atrial fibrillation (AF) in Europe after the release of the 2010 AF Guidelines of the European Society of Cardiology...
  3. doi request reprint Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial
    Paulus Kirchhof
    University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, Birmingham, UK Department of Cardiovascular Medicine, University Hospital Munster, Munster, Germany Kompetenznetz Vorhofflimmern e V AFNET e V, c o University of Münster, Munster, Germany Electronic address
    Am Heart J 166:442-8. 2013
    ..Rhythm control therapy has been only moderately effective in published trials, and its potential benefit was offset by side effects of repeated interventions...
  4. doi request reprint Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference
    Paulus Kirchhof
    Hospital of University of Münster, Munster, Germany
    Thromb Haemost 106:1012-9. 2011
    ..Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy...
  5. doi request reprint Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial
    Paulus Kirchhof
    Department of Cardiology and Angiology, Hospital of the University of Münster, Germany
    Lancet 380:238-46. 2012
    ..Therefore, we investigated whether short-term antiarrhythmic drug treatment after cardioversion is non-inferior to long-term treatment...
  6. doi request reprint [Atrial fibrillation: current recommendations for diagnosis and treatment]
    P Kirchhof
    Institute for Biomedical Research, University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, B15 2TT Birmingham, United Kingdom
    Internist (Berl) 54:583-95. 2013
    ..The choice of the rhythm-control therapy should be made based on safety considerations. Whether achieving sinus rhythm beyond improvement of symptoms improves the prognosis of AF is tested in ongoing trials...
  7. doi request reprint Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions
    P Kirchhof
    Department of Cardiology and Angiology, University Hospital Munster, Albert Schweitzer Straße 33, D 48149 Munster, Germany
    Thromb Haemost 105:1010-23. 2011
    ..Inpatients receive more rhythm control therapy. Adequate antithrombotic therapy is more often administered in specialist (cardiologist) centres...